Showing results (251-260 of 289) with videos related to
Sort By:
Pageof 29
Bone Marrow Transplantation|May 2, 2020
Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysisNosha Farhadfar, Hemant S Murthy, Brent R Logan, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 7, 2018
Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell TransplantationLinda J Burns, Beatrice Abbetti, Stacie D Arnold, et al.Blood|October 16, 2004
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populationsHakumei Oh, Fausto R Loberiza, Mei-jie Zhang, et al.Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)Joshua A Hill, Michael J Martens, Jo-Anne H Young, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2008
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR)Hillard M Lazarus, Jeanette Carreras, Christian Boudreau, et al.Blood Advances|November 4, 2020
Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphomaMarcelo C Pasquini, Zhen-Huan Hu, Kevin Curran, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2024
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational StudyJoshua A Hill, Michael J Martens, Jo-Anne H Young, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2014
Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for LeukemiaMichael Boyiadzis, Mukta Arora, John P Klein, et al.Blood|November 29, 2002
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphomaJohn E Levine, Richard E Harris, Fausto R Loberiza, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2008
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTRRichard F Schlenk, Marcelo C Pasquini, Waleska S Pérez, et al.Pageof 29